首页> Vaccines> Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022).

Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022).

导出 LinkOut

翻译打印收藏纠错

第一作者： Salvador,Domènech-Montoliu

第一单位： Emergency Service, University Hospital de la Plana, 12540 Vila-real, Spain.

作者： Salvador,Domènech-Montoliu ^[1] ; Joan,Puig-Barberà ^[2] ; Gema,Badenes-Marques ^[1] ; María,Gil-Fortuño ^[3] ; Alejandro,Orrico-Sánchez ^[2] ; María Rosario,Pac-Sa ^[4] ; Oscar,Perez-Olaso ^[3] ; Diego,Sala-Trull ^[1] ; Manuel,Sánchez-Urbano ^[1] ; Alberto,Arnedo-Pena ^[5]

作者单位： Emergency Service, University Hospital de la Plana, 12540 Vila-real, Spain. ^[1] Vaccine Research Unit (AIV), Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), 46020 Valencia, Spain. ^[2] Microbiology Service, University Hospital de la Plana, 12540 Vila-real, Spain. ^[3] Centro de Salud Pública de Castellón, 12003 Castelló de la Plana, Spain. ^[4] Centro de Salud Pública de Castellón, 12003 Castelló de la Plana, Spain.;Department of Health Science, Universidad Pública de Navarra, 31006 Pamplona, Spain. ^[5]

关键词 SARS-CoV-2 vaccination booster dose cellular immunity human long COVID prevalence risk factors

DOI 10.3390/vaccines11101590

PMID 37896992

发布时间 2023-10-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vaccines

2023年11卷10期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Vaccines

2023年11卷10期

检索历史清除

Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022).

Vaccines

相似文献

同项目论文

Vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022).

Vaccines

相似文献

同项目论文

Vaccines

相关期刊

检索历史清除